Kathy Lee-Sepsick
Founder, President, CEO & DirectorMs. Kathy Lee-Sepsick M.B.A, is Founder of Femasys Inc. and has been its Chief Executive Officer and President since February 2004. She served as Chairman of Board of Femasys Inc. since February 2004 until 2021 and has been its Director since February 2004. Ms. Lee-Sepsick has served as a senior executive in the medical technologies industry for nearly three decades, compiling a successful track record in growing emerging companies and corporate operating divisions. She holds over 100 patents globally for Femasys’ products and product candidates. Ms. Lee-Sepsick was instrumental in the various stages of product and company life cycles with stategic, operational and executive responsibilities, at start-ups Novoste Corporation, developer of intravascular therapy solution and SaluMedica, biomaterial developer of artificial cartilage. At the onset of her career, Ms. Lee-Sepsick served in a product management role at Terumo Medical Corporation, where she was integral in the management of strategic partner, Boston Scientific Corporation. Ms. Lee-Sepsick also serves on the Board of Directors of Georgia Bio. Ms. Lee-Sepsick is a graduate of Rutgers University with an MBA and a BS. in Biochemistry.
Positions
- Company NameFemasys Inc.Stock CodeFEMYPositionFounder, President, CEO & DirectorColleagues
- CECharles E. LarsenIndependent Non-Executive Chairman of Board
- DEDov ElefantChief Financial Officer
- JCJohn CanningChief Operating Officer
- JAJeremy Alexander SiposChief Technology Officer
- JHJames H. LiuChief Medical Officer
- AMAlistair MilnesIndependent Director
- EREdward R. UzialkoIndependent Director
- JMJohn MoorheadIndependent Director
